Contract Manufacturing

Voyager taps Brammer and Fujifilm for gene therapy development program

05-Dec-2018 By Melissa Fassbender

The clinical-stage gene therapy company Voyager Therapeutics has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand its manufacturing capabilities.

Catalent expands biologics facility, to create 36 new jobs

04-Dec-2018 By Maggie Lynch

Catalent is expanding its US biologics packaging facility, following recent investments and expansions in the Asia-Pacific region.

Gene therapy manufacturing partnership to support ‘booming’ market

03-Dec-2018 By Maggie Lynch

Axovant has signed a strategic partnership agreement with the CDMO Yposkesi to support its growing gene therapy pipeline.

People on the Move: Outsourcing-Pharma roundup November ‘18

30-Nov-2018 By Melissa Fassbender

ABL named a successor to its previous CEO, Syneos has two new hires, and BTS Research appointed a VP to push its growth model. These, among other people on the move this month.

Catalent’s China expansion to meet growing clinical trial industry

29-Nov-2018 By Maggie Lynch

Catalent’s existing clinical packaging facility in Shanghai is nearing the end of its expansion, ready to meet the needs of the growing Asia-Pacific region.

WuXi Biologics wins ABL Bio contract for bispecific antibodies

29-Nov-2018 By Flora Southey

South Korean biotech ABL Bio has selected WuXi Biologics to develop and manufacture up to eight bispecific antibodies for the clinic.

WuXi Biologics announces new discovery, development and manufacturing site in China

23-Nov-2018 By Flora Southey

The CDMO has broken ground on its 1.6 million-square-foot Biologics Innovation Center in Shanghai.

Cambrex acquires Avista for $252m, becomes integrated CDMO

21-Nov-2018 By Maggie Lynch

Cambrex is set to acquire Avista and enter the market of early stage small molecule development and testing.

World Courier making multi-million dollar tech investment

21-Nov-2018 By Maggie Lynch

World Courier has made a multimillion-dollar investment in its supply chain technology to help meet the expanding needs of the pharmaceutical industry.

Once significantly behind, China begins to close the drug development gap

20-Nov-2018 By Melissa Fassbender

Moving forward, China will take a more integral role in global drug development, following several regulatory changes designed to accelerate innovation.

Syneos revenue tops $1bn in Q3

19-Nov-2018 By Melissa Fassbender

Strong collaboration across the company’s clinical, commercial, and integration solutions teams led to a “solid performance,” said Syneos CEO Alistair MacDonald.

Quotient expands Reading facility tripling GMP capacity

15-Nov-2018 By Maggie Lynch

Quotient Sciences expanded its formulation development and clinical trial manufacturing operations at its Reading, UK facility.

Metrics completes serialization activities at NC-based site

15-Nov-2018 By Maggie Lynch

Metrics Contract Services’ newly-opened manufacturing site has qualified two commercial bottling lines for serialization with DSCSA requirements set to be enforced this month.

PCI continues expanding its offerings with new additions at Rockford clinical site

14-Nov-2018 By Maggie Lynch

PCI Pharma Services is expanding its clinical site in Rockford, IL – following a string of acquisitions and expansions to help meet an increased demand for services